Ryo Yano
Toon, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Efficacy of Luseogliflozin Added to Semaglutide in Patients With Metabolic Dysfunction-Associated Steatohepatitis and Type 2 Diabetes Mellitus: A Randomised, Open-Label Trial.
Journal: Diabetes, obesity & metabolism
Published: June 11, 2026
Fibrosis-4 Index as a Robust Long-Term Predictor of Cancers in Metabolic Dysfunction-Associated Steatotic Liver Disease.
Journal: Hepatology research : the official journal of the Japan Society of Hepatology
Published: January 14, 2026
Competing Cardiometabolic Pathways of Obesity and Metabolic Dysfunction-associated Steatotic Liver Disease.
Journal: Gastro hep advances
Published: October 11, 2025
Sequential metabolic cascade from normal liver to multimorbidity in lean Asian adults: Multistate progression modelling.
Journal: Diabetes & metabolic syndrome
Published: August 05, 2025
Outcome-Specific Cardiovascular and Hypertensive Risk Profiles in Metabolic Dysfunction-Associated Steatotic Liver Disease: Insights From a Competing Risk Cohort Analysis.
Journal: Gastro hep advances
Published: July 24, 2025
Evaluation of operator variability and technical accuracy of automatic image-based registration in liver fusion imaging.
Journal: Journal of medical ultrasonics (2001)
Published: June 26, 2025
Endoplasmic reticulum stress sensor protein PERK in hepatic stellate cells promotes the progression of hepatocellular carcinoma via p38δ MAPK/IL-1β axis.
Journal: Scientific reports
Published: March 13, 2025
Correction to: Deep attenuation transducer to measure liver stiffness in obese patients with liver disease.
Journal: Journal of medical ultrasonics (2001)
Published: March 04, 2024
Diagnostic accuracy of ultrasound-derived fat fraction for the detection and quantification of hepatic steatosis in patients with liver biopsy.
Journal: Journal of medical ultrasonics (2001)
Published: January 05, 2024
Last Updated: 09/26/2026